Volume Insights on Needleless IV Connector Sector

The global needleless IV connector sector volume projection was valued at 2,073.39 million units in 2023 and is projected to reach 3,141.36 million units by 2035, registering a CAGR of 3.5% from 2024 to 2035.

Volume Insights - A Strategic Overview

Allied Market Research announces the release of its comprehensive analysis of global needleless IV connectors. Needleless IV connectors are important medical devices used for fluid, medication administration, in patients. The growing burden of hospital admissions for various chronic diseases, surge in trauma cases, and post-surgical recovery needs is propelling the demand for IV therapy and subsequently needleless IV connector sector sales.

The report highlights needleless IV connector sector volume projection & demand across hospitals, long-term care facilities, and home healthcare settings. Product shipments have surged, fueled by advancements in design types, increased geriatric population, and rise in awareness about IV therapy.

The adoption of needleless IV connectors is also being fueled by the growing emphasis on infection management and preventing needlestick injuries. Needleless IV connectors, which also limit blood exposure and lower the risk of catheter-related bloodstream infections (CRBSIs), are becoming more popular among healthcare providers. Positive, neutral displacement mechanisms are examples of technological innovations that are boosting clinical outcomes and patient safety, making them an increasingly preferred option among healthcare providers, thereby driving needleless IV connector sector growth.

The moderate growth in shipments is attributed to the rise in adoption of home care services, increase in chronic disease prevalence, and government initiatives supporting technologies. The global volume of the needleless IV connector sector is expected to grow from 2,073.39 million units in 2023 to 3,141.36 million units by 2035, registering a CAGR of 3.5% over the forecast period. This is supported by surge in adoption of neutral displacement connectors as this design reduces the risk of blood reflux, making them a reliable option for various patient types and medical conditions due to their ability to lower the incidence of catheter occlusion and bloodstream infections, thereby driving needleless IV connector sector volume application for various indications.

Regional Needleless IV Connector Sector Volume Growth

Asia-Pacific dominates the needleless IV connectors sector with 39% share in 2023 and a 4.5% CAGR, while North America, Europe, and LAMEA show strong growth at 2.5%, 2.8%, and 3.7% CAGR respectively, driven by rise in hospital admissions requiring IV therapy and thus lead to high adoption of regional needleless IV connectors.

The regional analysis highlights significant variations in adoption trends and sector potential across the globe. Asia-Pacific leads the sector, contributing over 39% of the total volume in 2023 and is expected to grow at a CAGR of 4.5%, owing to increase in hospital admissions, a large elderly population, and government initiatives to enhance healthcare infrastructure.

North America led by the U.S. and Canada, is projected to maintain steady growth at a 2.5% CAGR, and Europe follow closely, with 2.8% CAGR with strong growth fueled by an aging population, surge in IV therapy adoption, and technological advancements, thereby driving the needleless IV connectors sector growth. LAMEA, with a 3.7% CAGR is emerging as a high-growth region, benefiting from increased healthcare investments and rise in burden of chronic diseases driving the adoption of IV therapy and subsequently needleless IV connectors.

Regional Needleless IV Connector Sector Volume Growth

Source: AMR Analysis 

Needleless IV Connector Country Sector Sales

U.S. leads the needleless IV connector sector and is projected to reach 412.26 million units and 548.17 million units by 2035 at 2.4% CAGR respectively, while India (4.8% CAGR) and China (5% CAGR) emerge as high-growth sectors driven by chronic diseases surge and aging population.

The report identifies the U.S. as the largest contributors to the needleless IV connector sector in terms of volume. U.S., with its extensive healthcare infrastructure and strong healthcare infrastructure, is projected to reach by 548.17 million units by 2035. U.S. remains an important player in North America, which is growing at a steady 2.4% CAGR.

Emerging countries such as China, India and Brazil are expected to drive significant growth due to their increasing focus on chronic disease. India and China, benefiting from government-led initiatives and the adoption of modern technology, are expected to cite a CAGR of 5.0% and 4.8% the highest among major countries, thereby driving the needleless IV connectors sector size. Brazil, representing Latin America, is projected to grow at a CAGR of 4.2%, supported by its expanding healthcare industry and favorable policies. 

Needleless IV Connector Sector Volume Share, By Country, 2023-2035 (Million Units) 

Source: AMR Analysis 

Key Highlights by Stakeholders

Highlighting the significance of this report, Anshul Mishra, Associate Vice-President of Allied Market Research, stated, “The rising demand for needleless IV connectors in chronic disease affected and post-surgical recovery patients remains opportunistic. Our latest report captures the sector's dynamics, providing actionable insights for stakeholders aiming to capitalize on this opportunity.” 

He further added, “Asia-Pacific, with its rapid healthcare expansion, remains the most promising region. At the same time, advancements in design types, and adoption of neutral displacement needleless IV connectors in North America and Europe are driving steady growth in these sectors. With this comprehensive analysis, we aim to empower our clients with the knowledge needed to make informed business decisions.”

Needleless IV Connector Sector Volume Trends

The report also emphasizes the growing role of needleless IV connectors in addressing the need for infection control and patient safety. With increasing regulatory standards and hospital protocols aimed at reducing healthcare-associated infections (HAIs), the shift toward advanced antimicrobial coated materials, neutral displacement needleless IV connectors due to their ability to lower the incidence of catheter occlusion and bloodstream infections are expected to witness a rise in the coming years.

This needleless IV connector sector trend is pushing manufacturers to develop connectors that enhance patient comfort while minimizing infection risks. These innovations are anticipated to increase demand for high-precision, specialized needleless IV connectors tailored to different patient needs, thereby driving needleless IV connector sector volume forecast.

Furthermore, the study explores the potential impact of global healthcare challenges, including aging populations, rise in chronic disease prevalence, and economic healthcare disparities. With increasing demand for home-based healthcare and advanced IV therapy products, the use of needleless IV connectors is expected to rise in both hospital and home settings.

Medical device manufacturers should use the report’s insights to grab new opportunities and plan ahead.